TY - JOUR
T1 - Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting
AU - La Vecchia, Luigi
AU - Bedogni, Francesco
AU - Finocchi, Giuseppe
AU - Mezzena, Gabriella
AU - Martini, Manuela
AU - Sartori, Maurizio
AU - Castellani, Antonio
AU - Soffiati, Guiliano
AU - Vincenzi, Mario
PY - 1996
Y1 - 1996
N2 - Objective: To assess whether and to what extent elective coronary stenting is associated with biochemical evidence of minor myocardial damage (MMD), as defined by the detection of abnormal post-procedural serum levels of one or more among the following markers of ischaemic injury: creatine kinase (CK)-MB mass, troponin T (Tn-T) and troponin I (Tn-I). Methods: Nineteen elective procedures of coronary stenting were compared with a matched group of 25 conventional percutaneous transluminal coronary angioplasty (PTCA) procedures performed in our laboratory from March to June 1995. Cases with evolving or recent (<2 weeks) myocardial infarction, chronic total occlusions and dilatation of saphenous vein grafts were excluded. By definition, all of the patients had undergone uneventful deployment of a single Palmaz-Schatz stent, with no chest pain and no persistent EGG changes after the procedure. Serum levels of CK-MB mass, Tn-T and Tn-I were determined at baseline and 6, 12 and 24 h after the procedure. The frequency of abnormal results was determined for each marker. Baseline and peak post-procedural levels in the two groups were compared and related to procedural variables. Results: Baseline values were normal in all cases. The quantitative analysis showed that post-procedural levels of each marker (including total CK) were significantly higher with respect to baseline in both groups. In the stent group, two patients had positive CK-MB mass, four positive Tn-T and seven positive Tn-I. Absolute changes in Tn-T and Tn-I were closely related to changes in CK-MB mass (r = 0.76, P
AB - Objective: To assess whether and to what extent elective coronary stenting is associated with biochemical evidence of minor myocardial damage (MMD), as defined by the detection of abnormal post-procedural serum levels of one or more among the following markers of ischaemic injury: creatine kinase (CK)-MB mass, troponin T (Tn-T) and troponin I (Tn-I). Methods: Nineteen elective procedures of coronary stenting were compared with a matched group of 25 conventional percutaneous transluminal coronary angioplasty (PTCA) procedures performed in our laboratory from March to June 1995. Cases with evolving or recent (<2 weeks) myocardial infarction, chronic total occlusions and dilatation of saphenous vein grafts were excluded. By definition, all of the patients had undergone uneventful deployment of a single Palmaz-Schatz stent, with no chest pain and no persistent EGG changes after the procedure. Serum levels of CK-MB mass, Tn-T and Tn-I were determined at baseline and 6, 12 and 24 h after the procedure. The frequency of abnormal results was determined for each marker. Baseline and peak post-procedural levels in the two groups were compared and related to procedural variables. Results: Baseline values were normal in all cases. The quantitative analysis showed that post-procedural levels of each marker (including total CK) were significantly higher with respect to baseline in both groups. In the stent group, two patients had positive CK-MB mass, four positive Tn-T and seven positive Tn-I. Absolute changes in Tn-T and Tn-I were closely related to changes in CK-MB mass (r = 0.76, P
KW - creatine kinase-MS mass
KW - ischaemic injury
KW - Palmaz-Schatz stent
KW - side-branch occlusion
KW - troponin I
KW - troponin T
UR - http://www.scopus.com/inward/record.url?scp=0029964739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029964739&partnerID=8YFLogxK
M3 - Article
C2 - 8913672
AN - SCOPUS:0029964739
VL - 7
SP - 535
EP - 540
JO - Coronary Artery Disease
JF - Coronary Artery Disease
SN - 0954-6928
IS - 7
ER -